PARENTE, Luca
 Distribuzione geografica
Continente #
AS - Asia 7.251
NA - Nord America 6.623
EU - Europa 2.527
SA - Sud America 222
AF - Africa 41
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 9
Totale 16.686
Nazione #
US - Stati Uniti d'America 6.504
HK - Hong Kong 4.465
SG - Singapore 1.214
IT - Italia 861
CN - Cina 696
UA - Ucraina 557
VN - Vietnam 465
DE - Germania 241
RU - Federazione Russa 217
IE - Irlanda 165
BR - Brasile 162
FI - Finlandia 144
FR - Francia 123
KR - Corea 120
CA - Canada 85
TR - Turchia 83
GB - Regno Unito 61
SE - Svezia 58
IN - India 53
AR - Argentina 26
BD - Bangladesh 26
MX - Messico 23
JP - Giappone 21
IQ - Iraq 19
PL - Polonia 16
ID - Indonesia 15
ES - Italia 14
NL - Olanda 14
EU - Europa 12
CZ - Repubblica Ceca 11
PK - Pakistan 10
CO - Colombia 9
ZA - Sudafrica 9
AT - Austria 7
EC - Ecuador 7
JO - Giordania 7
MY - Malesia 7
MA - Marocco 6
PH - Filippine 6
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
DZ - Algeria 5
MD - Moldavia 5
OM - Oman 5
TN - Tunisia 5
VE - Venezuela 5
BO - Bolivia 4
EG - Egitto 4
ET - Etiopia 4
HU - Ungheria 4
NP - Nepal 4
NZ - Nuova Zelanda 4
PA - Panama 4
CH - Svizzera 3
IL - Israele 3
KZ - Kazakistan 3
LT - Lituania 3
MK - Macedonia 3
RO - Romania 3
UZ - Uzbekistan 3
BA - Bosnia-Erzegovina 2
BE - Belgio 2
BG - Bulgaria 2
CL - Cile 2
DK - Danimarca 2
EE - Estonia 2
KE - Kenya 2
MN - Mongolia 2
MZ - Mozambico 2
PE - Perù 2
PY - Paraguay 2
TH - Thailandia 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BT - Bhutan 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GA - Gabon 1
HN - Honduras 1
IM - Isola di Man 1
JM - Giamaica 1
KG - Kirghizistan 1
KW - Kuwait 1
MC - Monaco 1
ME - Montenegro 1
MT - Malta 1
NO - Norvegia 1
PR - Porto Rico 1
PS - Palestinian Territory 1
RS - Serbia 1
SO - Somalia 1
SR - Suriname 1
Totale 16.681
Città #
Hong Kong 4.461
Ann Arbor 1.197
Singapore 695
Jacksonville 686
San Jose 593
Chandler 576
Princeton 445
Dallas 353
Ashburn 308
Dong Ket 295
Milan 292
Wilmington 264
Houston 180
Dublin 165
Nanjing 130
Council Bluffs 125
Woodbridge 123
Beijing 118
Andover 116
The Dalles 113
Lauterbourg 105
Pellezzano 100
Boardman 98
Rome 83
Salerno 83
Izmir 60
Dearborn 58
Shenyang 51
Hanoi 47
Ho Chi Minh City 45
Ottawa 45
Fairfield 43
Los Angeles 43
Munich 40
Jiaxing 36
New York 36
Changsha 34
Nanchang 30
Hebei 28
Santa Clara 28
Frankfurt am Main 26
Moscow 25
Turku 25
São Paulo 24
Mestre 23
Düsseldorf 22
Figino 22
Orem 22
Tokyo 21
Denver 20
Tianjin 20
Chicago 19
Montreal 19
Norwalk 19
Jinan 17
Falls Church 16
Turin 16
Washington 15
London 14
Warsaw 14
Atlanta 12
Brooklyn 12
Redwood City 12
San Diego 12
Chennai 11
Columbus 11
Phoenix 11
Stockholm 11
Belo Horizonte 10
Guangzhou 10
Manchester 10
Naples 10
San Francisco 10
Bologna 9
Dhaka 9
Napoli 9
Poplar 9
Pune 9
Amsterdam 8
Boston 8
Cambridge 8
Charlotte 8
Da Nang 8
Mumbai 8
Seattle 8
Ankara 7
Brno 7
Campinas 7
Hangzhou 7
Jakarta 7
Seoul 7
Shanghai 7
Baghdad 6
Des Moines 6
Gragnano 6
Helsinki 6
Istanbul 6
Kunming 6
Memphis 6
Mexico City 6
Totale 13.067
Nome #
Histone deacetylase inhibitor FR235222 sensitizes human prostate adenocarcinoma cells to apoptosis through up-regulation of annexin A1. 1.281
Hydrocortisone and 'macrocortin' inhibit the zymosan-induced release of lyso-PAF from rat peritoneal leucocytes. 861
Effects of Prisma® Skin dermal regeneration device containing glycosaminoglycans on human keratinocytes and fibroblasts 629
miR-196a Is Able to Restore the Aggressive Phenotype of Annexin A1 Knock-Out in Pancreatic Cancer Cells by CRISPR/Cas9 Genome Editing 620
Role of Annexin A1 in mouse myoblast cell differentiation 612
Structure-Based Design, Synthesis and Preliminary Anti-inflammatory Activity of Bolinaquinone Analogues 375
Annexin A1 N-Terminal Derived Peptide Ac2-26 Stimulates Fibroblast Migration in High Glucose Conditions. 323
Annexin A1 Induces Skeletal Muscle Cell Migration Acting through Formyl Peptide Receptors. 289
Advances in the pathophysiology of constitutive and inducible cyclooxygenase: two enzymes in the spotlight. 252
Role of intracellular and extracellular annexin A1 in migration and invasion of human pancreatic carcinoma cells. 241
Dexamethasone inhibits TRAIL-induced apoptosis of thyroid cancer cells via Bcl-xL induction. 222
Evaluation of in situ injectable hydrogels as controlled release device for ANXA1 derived peptide in wound healing 209
14,15-Secopregnane Derivatives from the Leaves of Solenostemma argel. 208
Annexin A1 contributes to pancreatic cancer cell phenotype, behaviour and metastatic potential independently of Formyl Peptide Receptor pathway 194
Annexin A1 Contained in Extracellular Vesicles Promotes the Activation of Keratinocytes by Mesoglycan Effects: An Autocrine Loop Through FPRs 189
Annexin A1: Novel Roles in Skeletal Muscle Biology 186
Annexin A1 is involved in the acquisition and maintenance of a stem cell-like/aggressive phenotype in prostate cancer cells with acquired resistance to zoledronic acid 179
The pharmaceutical device prisma® skin promotes in vitro angiogenesis through endothelial to mesenchymal transition during skin wound healing 167
Cl-IB-MECA inhibits human thyroid cancer cell proliferation independently of A3 adenosine receptor activation 166
La macrocortina un inibitore della fosfolipasi indotto dai glucocorticoidi 166
Annexin A1 May Induce Pancreatic Cancer Progression as a Key Player of Extracellular Vesicles Effects as Evidenced in the In Vitro MIA PaCa-2 Model System 166
Carrageenan-induced mouse paw oedema is biphasic, age-weight dependent and displays differential nitric oxide cyclooxygenase-2 expression. 154
Effects of FR235222, a novel HDAC inhibitor, in proliferation and apoptosis of human leukaemia cell lines: role of annexin A1 150
Hypoxia regulates ANXA1 expression to support prostate cancer cell invasion and aggressiveness 149
Annexin 1: more than an antiphospholipase protein 147
ROLE OF ANNEXIN A1 IN MIGRATION OF HUMAN PANCREATIC CARCINOMA CELL LINES 146
R-roscovitine sensitizes anaplastic thyroid carcinoma cells to TRAIL-induced apoptosis via regulation of IKK/NF-kB pathway. 145
A new pharmaceutical device containing mesoglycan modulates fibroblasts function in vivo 139
4-Substituted-5-acetyl-2-methyl-6-phenyl-3(2H)pyridazinones as PGE2 and IL-1 release inhibitors from mouse adherent macrophages 138
Annexin-1 downregulation in thyroid cancer correlates to the degree of tumor differentiation 136
Alpha-melanocyte-stimulating hormone reduces interleukin-1 beta effects on rat stomach preparations possibly through interference with a type I receptor. 133
Anti-inflammatory effects of annexin-1: stimulation of IL-10 release and inhibition of nitric oxide synthesis 130
A novel anti-inflammatory peptide from human lipocortin 5. 125
Anaphylactic release of platelet activating factor acether and eicosanoids from lungs of guinea pigs sensitized to ovalbumin aerosol. 122
Glucocorticoidi 119
LGP1 STIMULATES APOPTOSIS IN U937 ASSOCIATED TO INCREASED ANNEXIN A1 PROTEIN EXPRESSION 119
Human eosinophil chemotaxis and selective in vivo recruitment by sphingosine 1-phosphate. 117
Anti-inflammatory effect of tuftsin and its retro-inverso analogue in rat adjuvant arthritis 117
Activation of gene expression by interleukin 1. 115
A comparison of the acute inflammatory response in adrenalectomised and sham-operated rats. 112
Studies on cell motility in inflammation. I. The chemotactic activity of experimental, immunological and non-immunological, inflammatory exudates. 112
The release of interleukin-1-like activity by macrophages in two models of immunological inflammation in the rat. 109
Induction of gene expression by IL-1 in NIH 3T3 cells. Possible requirement of protein kinase C activity and independence from arachidonic acid metabolism. 105
Induction of annexin-1 during TRAIL-induced apoptosis in thyroid carcinoma cells 103
Rectal temperture and prostaglandin E2 increase in cerebrospinal fluid of conscious rabbits after intracerebroventricular injection of hemoglonin. 103
Consensus italiana sulle raccomandazioni EULAR 2005 per il trattamento dell’artrosi dell’anca. 103
LGP1, a histone deacetylase inhibitor analogue of FR235222, sensitizes promyelocytic leukemia U937 cells to TRAIL-mediated apoptosis 103
5-Lipoxygenase activation may facilitate an interleukin-1 transduction signal. 102
Endothelial nitric oxide synthase activation is critical for vascular leakage during acute inflammation in vivo. 101
Farmaci antinfiammatori steroidei 101
Evidence for the neuronal origin of immunoreactive interleukin-1beta released by rat hypothalamic explants. 101
The effect of adrenalectomy on interleukin-1 release in vitro and in vivo. 100
Mesoglycan induces the secretion of microvesicles by keratinocytes able to activate human fibroblasts and endothelial cells: A novel mechanism in skin wound healing 100
Consensus italiana sulle raccomandazioni dell’EULAR 2003 per il trattamento dell’artrosi del ginocchio. 99
Dexamethasone-induced cytotoxic activity and drug resistance effects in androgen-independent prostate tumor PC-3 cells are mediated by lipocortin 1. 99
Histone Deacetylase Inhibitors in the Treatment of Hematological Malignancies 98
Synthetic alleles at position 121 define a functional domain of human interleukin-1beta 97
I GLICOCORTICOIDI 96
Association between glucocorticoids and lipocortin-1 96
Modulation of phospholipase A2 activity in human fibroblasts. 96
Corticosteroids microparticles produced by supercritical assisted atomization: process optimization, products characterization and “in vitro” performance 94
Evidence that endogenous interleukin-1 is involved in leukocyte migration in acute experimental inflammation in rats and mice. 93
Gastric antisecretory and anti-ulcer actions of interleukin-1 in rat involve different interleukin-1 receptor types 93
Anti-phospholipase proteins. 93
Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids. 92
The annexin 1-/- mouse. 91
Interleukin-1 receptor antagonist displays intrinsic agonist activity on rat gastric fundus motility in vitro 91
Are the lipocortins the second messengers of the anti-inflammatory action of glucocorticoids? 91
Human annexin 1 is highly expressed during the differentiation of the epithelial cell line A 549: involvement of nuclear factor interleukin 6 in phorbol ester induction of annexin 1. 90
Immunostimulation by a partially modified retro-inverso-tuftsin analogue containing Thr1 psi[NHCO](R,S)Lys2 modification. 90
Arachidonic acid lipoxygenation may be involved in interleukin-1 induction of prostaglandin biosynthesis. 90
IL-6 stimulates annexin 1 expression and translocation and suggests a new biological role as Class II acute phase protein. 89
The effect of steroid treatment on lipocortin immunoreactivity of rat brain 89
Identification of several species of phospholipase inhibitory protein(s) by radioimmunoassay for lipomodulin. 89
Proteinase-activated receptor-2 mediates arterial vasodilatation in diabetes 88
Khellin, but not 8-methoxylpsoralen, inhibits adenylyl cyclase system in HeLa cells 88
Gene structure of the Helicobacter pylori cytotoxin and evidence of its role in gastric disease. 86
Peptide 204-212 of lipocortin 5 inhibits the generation of a prostacyclin-like factor from rat aorta preparations in vitro. 86
Prostaglandin E2 and bacterial lipopolysaccharide stimulate bioactive interleukin-1 release from rat hypothalamic explants. 85
Down-regulation of microglial cyclooxygenase-2 and inducible nitric oxide synthase expression by lipocortin 1. 83
Sequential release of TNFalfa and phospholipase A2 in a rat model of LPS-induced pleurisy. 83
Macrophage-specific eicosanoid synthesis inhibition and lipocortin-1 induction by glucocorticoids. 83
The effect of glucocorticoids on lyso-PAF formation in vitro and in vivo. 83
Evidence that interleukin-1beta and tumor necrosis factor inhibit gastric fundus motility via the 5-lipoxygenase pathway. 82
Mechanisms underlying the protective effects of interleukin-1 in experimental NSAID-gastropathy. 82
Pros and cons of selective inhibition of cyclooxygenase-2 versus dual lipoxygenase/cyclooxygenase inhibition: is two better than one? 80
Dexamethasone induces the expression of the mRNA of lipocortin 1 and 2 and the release of lipocortin 1 and 5 in differentiated, but not undifferentiated U-937 cells. 80
Effect of dexamethasone and phorbol myristate acetate on lipocortin 1, 2 and 5 mRNA and protein synthesis. 80
Suppression of arachidonate oxidation by glucocorticoid-induced antiphospholipase peptides. 80
Induction of annexin-1 at transcriptional and post-transcriptional level in rat brain by methylprednisolone and the 21-aminosteroid U74389F. 79
Interleukin-1beta- and tumor necrosis factor-induced inhibition of rat gastric fundus motility in vitro. 78
Conceivable difference in the anti-inflammatory mechanisms of lipocortins 1 and 5. 78
The cyclo-oxygenase pathway in the avascular heart of the frog, Rana esculenta L. 77
Glucocorticoids induce the formation and release of anti-inflammatory and anti-phospholipase proteins into the peritoneal cavity of the rat. 77
Effects of steroids on brain lipocortin immunoreactivity. 75
Relationship between the anti-phospholipase and anti-inflammatory effects of glucocorticoid-induced proteins. 75
Cytokines and eicosanoids in cancer drug toxicity. 74
Reduction of aspirin-induced gastric damage in rats by interleukin-1beta: possible involvement of endogenous corticosteroids. 74
Increase of extracellular brain calcium is involved in interleukin-1beta-induced pyresis in the rabbit; antagonism by dexamethasone 74
Loop substitution as a tool to identify active sites of interleukin 1beta 73
Totale 15.430
Categoria #
all - tutte 48.429
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.429


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022776 0 0 0 13 16 23 6 30 123 110 103 352
2022/20231.388 127 83 18 158 185 298 0 161 243 5 92 18
2023/2024456 50 71 35 22 50 46 29 26 8 19 20 80
2024/20251.121 63 15 9 48 44 126 210 121 155 35 134 161
2025/20268.413 1.851 2.029 1.181 190 515 260 906 144 242 483 90 522
2026/202735 35 0 0 0 0 0 0 0 0 0 0 0
Totale 16.894